{"id":"https://openalex.org/W4396991965","doi":"https://doi.org/10.1681/asn.20213210s1402a","title":"RGLS4326 Increases Urinary PC1 and PC2 Levels in Individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)","display_name":"RGLS4326 Increases Urinary PC1 and PC2 Levels in Individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W4396991965","doi":"https://doi.org/10.1681/asn.20213210s1402a"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20213210s1402a","doi":"https://doi.org/10.1681/asn.20213210s1402a","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20213210s1402a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010032928","display_name":"Edmund Lee","orcid":"https://orcid.org/0000-0001-9112-4460","observed_orcids":["https://orcid.org/0000-0001-9112-4460"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edmund Lee","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109717294","display_name":"Tania M. Valencia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tania M. Valencia","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061270196","display_name":"Tate Owen","orcid":"https://orcid.org/0009-0006-3305-2423","observed_orcids":["https://orcid.org/0009-0006-3305-2423"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tate Owen","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111597819","display_name":"S Neben","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Neben","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052677780","display_name":"Karl F. Cremer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl F. Cremer","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100597883","display_name":"Rekha Garg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rekha Garg","raw_affiliation_strings":["PharmaDRS Consulting LLC, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaDRS Consulting LLC, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050272324","display_name":"Denis Drygin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denis Drygin","raw_affiliation_strings":["Regulus Therapeutics Inc, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc, San Diego, CA;","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101970592","display_name":"Christopher J. Ward","orcid":"https://orcid.org/0000-0002-2507-9398","observed_orcids":["https://orcid.org/0000-0002-2507-9398"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Ward","raw_affiliation_strings":["University of Kansas Medical Center, Kansas City, KS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas Medical Center, Kansas City, KS;","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048311675","display_name":"Alan S.L. Yu","orcid":"https://orcid.org/0000-0002-1776-2533","observed_orcids":["https://orcid.org/0000-0002-1776-2533"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan S. Yu","raw_affiliation_strings":["University of Kansas Medical Center, Kansas City, KS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas Medical Center, Kansas City, KS;","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083795868","display_name":"Vishal Patel","orcid":"https://orcid.org/0000-0003-2875-4659","observed_orcids":["https://orcid.org/0000-0003-2875-4659"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vishal Patel","raw_affiliation_strings":["The University of Texas Southwestern Medical Center Department of Internal Medicine, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center Department of Internal Medicine, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"10S","first_page":"402","last_page":"402"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11412","display_name":"Genetic and Kidney Cyst Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11412","display_name":"Genetic and Kidney Cyst Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/autosomal-dominant-polycystic-kidney-disease","display_name":"autosomal dominant polycystic kidney disease","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pc1","display_name":"PC1","score":0.7429999709129333},{"id":"https://openalex.org/keywords/pc2","display_name":"PC2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pkd1","display_name":"PKD1","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pkd2","display_name":"PKD2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oligonucleotide-therapeutics","display_name":"oligonucleotide therapeutics","score":0.800000011920929},{"id":"https://openalex.org/keywords/kidney-injury-biomarkers","display_name":"kidney injury biomarkers","score":0.5659999847412109},{"id":"https://openalex.org/keywords/kim-1","display_name":"KIM-1","score":0.9430000185966492},{"id":"https://openalex.org/keywords/neutrophil-gelatinase-associated-lipocalin","display_name":"neutrophil gelatinase-associated lipocalin","score":0.9570000171661377},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.656000018119812},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.652999997138977},{"id":"https://openalex.org/keywords/cyst-growth","display_name":"cyst growth","score":0.6539999842643738},{"id":"https://openalex.org/keywords/renal-tubules","display_name":"renal tubules","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C2776266639","wikidata":"https://www.wikidata.org/wiki/Q2732398","display_name":"Autosomal dominant polycystic kidney disease","level":3,"score":0.8771730661392212},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.6346741914749146},{"id":"https://openalex.org/C2780145431","wikidata":"https://www.wikidata.org/wiki/Q15443105","display_name":"Polycystic kidney disease","level":3,"score":0.5775030255317688},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5759150385856628},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5079548954963684},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.49702218174934387},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4707271158695221},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.45609936118125916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44255414605140686},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.42549100518226624},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4232070744037628},{"id":"https://openalex.org/C3018663864","wikidata":"https://www.wikidata.org/wiki/Q15443105","display_name":"Polycystic kidney","level":3,"score":0.4198514223098755},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3804871439933777}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20213210s1402a","doi":"https://doi.org/10.1681/asn.20213210s1402a","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20213210s1402a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403831212","https://openalex.org/W4397024494","https://openalex.org/W2803912864","https://openalex.org/W2972652035","https://openalex.org/W7161117175","https://openalex.org/W4403830992","https://openalex.org/W2015774770","https://openalex.org/W2953009717","https://openalex.org/W4416876136","https://openalex.org/W2083325490"],"abstract_inverted_index":{"Background:":[0],"ADPKD":[1,37,83,332],"is":[2,96],"caused":[3],"by":[4],"mutations":[5],"of":[6,16,44,122,158,210,212,235,261,280,297,318],"either":[7],"PKD1":[8],"or":[9,130,161],"PKD2":[10],"genes,":[11],"leading":[12],"to":[13,48,98,228,294],"reduced":[14],"function":[15],"their":[17,31],"respective":[18],"protein":[19],"products":[20],"PC1":[21,60,77,173,255,277,308],"and":[22,30,51,57,61,63,78,103,128,137,163,174,183,238,245,256,269,278,282,305,309,320],"PC2.":[23,310],"Both":[24],"proteins":[25],"are":[26,154],"secreted":[27],"in":[28,67,80,105,201,250,253,276,322],"exosomes,":[29,177],"urinary":[32,170],"levels":[33,241],"inversely":[34],"correlate":[35],"with":[36,82,107,120,219,231,272,299],"severity.":[38],"RGLS4326,":[39],"a":[40,232,328],"novel":[41],"oligonucleotide":[42],"inhibitor":[43],"miR-17,":[45],"preferentially":[46],"delivers":[47,293],"kidney":[49,178],"tubules":[50],"cysts,":[52],"derepresses":[53,307],"miR-17":[54,304,326],"targets":[55],"Pkd1":[56,319],"Pkd2,":[58],"increases":[59],"PC2,":[62],"attenuates":[64],"cyst":[65],"growth":[66],"multiple":[68],"PKD":[69],"mouse":[70],"models.":[71],"Whether":[72],"RGLS4326":[73,100,124,213,215,292],"treatment":[74],"would":[75],"increase":[76,275],"PC2":[79,175,257,279],"individuals":[81,106,298],"was":[84,216],"unknown.":[85],"Methods:":[86],"An":[87],"open-label,":[88],"adaptive":[89],"design,":[90],"dose-ranging,":[91],"Phase":[92],"1b":[93],"clinical":[94,289],"study":[95,110,262],"ongoing":[97,315],"evaluate":[99],"safety,":[101],"pharmacodynamics":[102],"pharmacokinetics":[104],"ADPKD.":[108],"The":[109,150,169,311],"will":[111,138],"enroll":[112],"\u02dc27":[113],"patients":[114,190],"(9":[115],"per":[116],"cohort)":[117],"treated":[118],"subcutaneously":[119],"one":[121],"three":[123],"doses":[125,209],"(1,":[126],"0.3,":[127],"0.1":[129],"0.5":[131],"mg/kg":[132],"Q2W":[133],"\u00d7":[134],"4":[135],"doses)":[136],"be":[139],"followed":[140],"for":[141,331],"28":[142],"days":[143],"after":[144,242],"the":[145,202,243,259],"last":[146],"dose":[147,247],"(Day":[148],"71).":[149],"major":[151],"inclusion":[152],"criteria":[153],"Mayo":[155],"Imaging":[156],"Classification":[157],"1C,":[159],"1D,":[160],"1E,":[162],"GFR":[164,192],"between":[165],"30-90":[166],"mL/min/1.73":[167],"m2.":[168],"biomarkers":[171],"include":[172],"on":[176],"injury":[179],"marker":[180],"1":[181],"(KIM1),":[182],"neutrophil":[184],"gelatinase-associated":[185],"lipocalin":[186],"(NGAL).":[187],"Results:":[188],"Nine":[189],"(mean":[191],"49":[193],"mL/min/1.73m2,":[194],"mean":[195,273],"age":[196],"50":[197],"yr)":[198],"were":[199,226,265],"enrolled":[200],"first":[203,244],"cohort;":[204],"each":[205],"patient":[206],"received":[207],"four":[208],"1mg/kg":[211],"Q2W.":[214],"well":[217],"tolerated":[218],"no":[220],"serious":[221],"adverse":[222],"events.":[223],"PK":[224],"profiles":[225],"similar":[227],"healthy":[229],"volunteers,":[230],"plasma":[233,239],"half-life":[234],"9":[236],"hours":[237],"AUC":[240],"fourth":[246],"\u02dc2x":[248],"higher":[249],"patients.":[251],"Changes":[252],"both":[254],"at":[258],"end":[260],"from":[263],"baseline":[264],"statistically":[266],"significant":[267],"(p=0.0004":[268],"p=0.026,":[270],"respectively),":[271],"%":[274],"58%":[281],"38%,":[283],"respectively.":[284],"Conclusions:":[285],"These":[286],"data":[287],"provide":[288],"proof":[290],"that":[291],"cystic":[295],"kidneys":[296],"ADPKD,":[300],"where":[301],"it":[302],"inhibits":[303],"thereby":[306],"results":[312],"also":[313],"imply":[314],"miR-17-mediated":[316],"repression":[317],"Pkd2":[321],"humans,":[323],"further":[324],"validating":[325],"as":[327],"therapeutic":[329],"target":[330],"treatment.":[333],"Funding:":[334],"Commercial":[335],"Support":[336],"-":[337],"Regulus":[338],"Therapeutics":[339]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-18T00:00:00"}